(VIANEWS) – NASDAQ Composite ended the session with Moderna rising 8.42% to $419.05 on Wednesday, following the last session’s upward trend. NASDAQ Composite rose 0.13% to $14,780.53, after two successive sessions in a row of gains, on what was a somewhat positive trend trading session today.
Today’s last reported volume for Moderna is 31901200, 144.76% above its average volume of 13033500.
Moderna’s last close was $386.51, 6.77% above its 52-week high of $362.00.
Moderna’s sales growth is 6347.1% for the ongoing quarter and 7189.7% for the next. The company’s growth estimates for the current quarter and the next is 2048.4% and 1439%, respectively.
Year-on-year quarterly revenue growth grew by 24112.5%, now sitting on 2.73B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Moderna’s stock is considered to be oversold (<=20).
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $419.05 at 17:14 EST, way higher than its 52-week high of $362.00.
Moderna’s Moving Average
Moderna’s value is way higher than its 50-day moving average of $257.86 and way above its 200-day moving average of $183.99.
More news about Moderna (MRNA).